Taking people in ArgentinaPhase 3
Orforglipron and Heart Events in People With Heart Artery Disease or Chronic Kidney Disease
Tests orforglipron against placebo for heart problems in adults with artery or kidney disease.
Plain-language title generated from the registry record
Registry title: A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Key facts
- Where
- Bahía Blanca, Buenos Aires, C.a.b.a., CABA, Córdoba, Corrientes, Esperanza, Godoy Cruz, Granadero Baigorria, Junín, Lanus, Mar del Plata, Mendoza, Quilmes, Ramos Mejía, Río Cuarto, Rosario, S3000epv, San Isidro, SAN M. de Tucuman, San Martin, San Miguel de Tucumán, San Nicolás, Santa Fe, Santa Rosa, Venado Tuerto, and Zárate, ArgentinaSee the 58 sites
- Phase
- Phase 3
Where in Argentina
- Instituto de Investigaciones Clínicas Bahia BlancaBahía Blanca, ArgentinaTaking people
- Buenos Aires Macula S.ABuenos Aires, ArgentinaTaking people
- Cardiología PalermoBuenos Aires, ArgentinaTaking people
- CEMEDICBuenos Aires, ArgentinaTaking people
- Centro de Investigaciones Metabólicas (CINME)Buenos Aires, ArgentinaTaking people
- Centro Medico Dra. Laura Maffei- Investigacion Clinica AplicadaBuenos Aires, ArgentinaTaking people
- Centro Médico ViamonteBuenos Aires, ArgentinaTaking people
- Cicemo SrlBuenos Aires, ArgentinaTaking people
- CIPRECBuenos Aires, ArgentinaTaking people
- CONEXA Investigacion Clinica S.A.Buenos Aires, ArgentinaTaking people
- Consultorio Medico Investigador Principal Dr BesadaBuenos Aires, ArgentinaTaking people
- Fundacion RespirarBuenos Aires, ArgentinaTaking people
- Glenny Corp. S.A.Buenos Aires, ArgentinaTaking people
- Instituto Médico Especializado (IME)Buenos Aires, ArgentinaTaking people
- Investigaciones Medicas Imoba SrlBuenos Aires, ArgentinaTaking people
- Mautalen Salud e InvestigaciónBuenos Aires, ArgentinaTaking people
- Organización Médica de InvestigaciónBuenos Aires, ArgentinaTaking people
- Stat Research S.A.Buenos Aires, ArgentinaTaking people
- CEMEDIABC.a.b.a., ArgentinaTaking people
- CEDICCABA, ArgentinaTaking people
- Centro Diabetológico Dr. WaitmanCórdoba, ArgentinaTaking people
- Centro Medico Privado San Vicente DiabetesCórdoba, ArgentinaTaking people
- Hospital Italiano De CordobaCórdoba, ArgentinaTaking people
- Instituto de Investigaciones Clínicas CórdobaCórdoba, ArgentinaTaking people
- Instituto Médico DAMICCórdoba, ArgentinaTaking people
- Instituto de Cardiología "Juana F. Cabral"Corrientes, ArgentinaTaking people
- Sanatorio EsperanzaEsperanza, ArgentinaTaking people
- CIPADI - Centro Integral de Prevencion y Atencion en DiabetesGodoy Cruz, ArgentinaTaking people
- Centro de Investigaciones Clínicas BaigorriaGranadero Baigorria, ArgentinaTaking people
- Centro de Salud Renal JunínJunín, ArgentinaTaking people
- CIMeLLanus, ArgentinaTaking people
- Centro de Investigaciones Medicas Mar Del PlataMar del Plata, ArgentinaTaking people
- Instituto de Investigaciones Clinicas Mar del PlataMar del Plata, ArgentinaTaking people
- Instituto de Cardiología WolffMendoza, ArgentinaTaking people
- CER medical InstituteQuilmes, ArgentinaTaking people
- DIM Clínica PrivadaRamos Mejía, ArgentinaTaking people
- Instituto Médico Río CuartoRío Cuarto, ArgentinaTaking people
- Fundacion Estudios ClinicosRosario, ArgentinaTaking people
- Fundación InnovacienciaRosario, ArgentinaTaking people
- Hospital Provincial del CentenarioRosario, ArgentinaTaking people
- INECO Neurociencias OroñoRosario, ArgentinaTaking people
- Instituto de Investigaciones Clinicas RosarioRosario, ArgentinaTaking people
- Instituto Especialidades de la Salud RosarioRosario, ArgentinaTaking people
- Instituto Médico Catamarca IMECRosario, ArgentinaTaking people
- Instituto Médico Fundación Grupo Colaborativo Rosario Investigación y Prevención MedicaRosario, ArgentinaTaking people
- Laboratorio de Hemostasia y TrombosisRosario, ArgentinaTaking people
- Clínica de Nefrología, Urología y Enfermedades CardiovascularesS3000epv, ArgentinaTaking people
- Santa Maria de la Salud Centro MedicoSan Isidro, ArgentinaTaking people
- Centro de Investigaciones Médicas TucumanSAN M. de Tucuman, ArgentinaTaking people
- Corporación Médica San MartínSan Martin, ArgentinaTaking people
- Centro Modelo de CardiologíaSan Miguel de Tucumán, ArgentinaTaking people
- Investigaciones Clínicas TucumánSan Miguel de Tucumán, ArgentinaTaking people
- Go Centro Medico San NicolásSan Nicolás, ArgentinaTaking people
- Centro de Diagnóstico y Rehabilitación (CEDIR)Santa Fe, ArgentinaTaking people
- Centro de Investigaciones Clinicas del LitoralSanta Fe, ArgentinaTaking people
- Centro de Salud e Investigaciones MédicasSanta Rosa, ArgentinaTaking people
- Sanatorio San MartinVenado Tuerto, ArgentinaTaking people
- Instituto de Investigaciones Clinicas ZarateZárate, ArgentinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Eli Lilly and Company
- Trial code
- NCT07241390EU 2025-523123-22-00
- Record updated
- 4 November 2026
- Original description
The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.Read full original descriptionShow less
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Orforglipron on the Incidence of Major Adverse Cardiovascular Events in Participants With Established Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.
Inclusion: Have established ASCVD and/or CKD.
Exclusion: Have had a major heart condition within 60 days prior to screening; Have type 1 diabetes; Have New York Heart Association Functional Classification Class IV heart failure.